user

Trends in Reporting of Nuchal Translucency Measurements After the Clinical Introduction of Cell-Free DNA Screening

被引：1
|
作者：
Wen, Timothy [1 ]
Thornburg, Loralei L.
Norton, Mary E.
Platt, Lawrence D.
Dugoff, Lorraine
Hesson, Ashley
Spitz, Jean L.
Toland, Gregory
Bromley, Bryann
机构：
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA 94115 USA
来源：
OBSTETRICS AND GYNECOLOGY | 2024年 / 143卷 / 06期
关键词：
D O I：
10.1097/AOG.0000000000005577
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Reporting of nuchal translucency measurements as part of first-trimester aneuploidy screening has decreased steadily since the introduction of cell-free DNA screening in 2012. Nuchal translucency (NT) measurement in conjunction with serum analytes has been used for first-trimester aneuploidy screening in the United States since 2005. We sought to analyze the trends in reporting of NT measurements to the Nuchal Translucency Quality Review program in all pregnancies beginning after the clinical introduction of cell-free DNA (cfDNA) screening for fetal aneuploidy in 2011. Overall, reported NT measurements decreased 74.3% from 2012 to 2022. A similar decline was noted among individuals with pregnancies at increased risk for aneuploidy based on patient age and twin gestations. The decrease in reporting aligns temporally with the availability of cfDNA screening and the coronavirus disease 2019 (COVID-19) pandemic.
引用
收藏
页码：811 / 814
页数：4
相关论文
共 50 条
  • [1] Trends in volume of nuchal translucency scans and credentialed providers since introduction of cell-free DNA
    Bromley, Bryann
    Thornburg, Loralei L.
    Fuchs, Karin
    Dugoff, Lorraine
    Toland, Gregory J.
    Platt, Lawrence D.
    Norton, Mary E.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S629 - S630
  • [2] Trends in volume of nuchal translucency scans for twin pregnancies since introduction of cell-free DNA
    Dugoff, Lorraine
    Bromley, Bryann
    Thornburg, Loralei L.
    Fuchs, Karin
    Platt, Lawrence D.
    Toland, Gregory J.
    Norton, Mary E.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S306 - S307
  • [3] Abnormal nuchal translucency: residual risk with normal cell-free DNA screening
    Grossman, Tracy B.
    Bodenlos, Kimberly L.
    Chasen, Stephen T.
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020, 33 (18): : 3062 - 3067
  • [4] Does maternal age impact nuchal translucency utilization since the introduction of cell-free DNA
    Thornburg, Loralei L.
    Platt, Lawrence D.
    Toland, Gregory J.
    Dugoff, Lorraine
    McIntosh, Jennifer
    Fuchs, Karin
    Norton, Mary E.
    Bromley, Bryann
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S600 - S601
  • [5] Value of increased nuchal translucency in the era of cell-free DNA testing
    Zhen, L.
    Li, D. -Z.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2020, 55 (05) : 697 - +
  • [6] The utility of nuchal translucency ultrasound in identifying rare chromosomal abnormalities not detectable by cell-free DNA screening
    Berger, Victoria K.
    Norton, Mary E.
    Sparks, Teresa N.
    Flessel, Monica
    Baer, Rebecca J.
    Currier, Robert J.
    [J]. PRENATAL DIAGNOSIS, 2020, 40 (02) : 185 - 190
  • [7] Value of increased nuchal translucency in the era of cell-free DNA testing Reply
    Miranda, J.
    Borrell, A.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2020, 55 (05) : 698 - 699
  • [8] Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda, J.
    Mino, F. Paz Y.
    Borobio, V
    Badenas, C.
    Rodriguez-Revenga, L.
    Pauta, M.
    Borrell, A.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2020, 55 (05) : 645 - +
  • [9] Value of increased nuchal translucency in the era of noninvasive prenatal testing with cell-free DNA
    Holzer, Iris
    Husslein, Peter W.
    Bettelheim, Dieter
    Scheidt, Julia
    Kiss, Herbert
    Farr, Alex
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 145 (03) : 319 - 323
  • [10] First-trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell-free DNA
    Johnson, J.
    Pastuck, M.
    Metcalfe, A.
    Connors, G.
    Krause, R.
    Wilson, D.
    Cuckle, H.
    [J]. PRENATAL DIAGNOSIS, 2013, 33 (11) : 1044 - 1049
12345